Business
Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016
Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016.
About this update from Plandai Biotechnology, Inc.
[{"type":"text","content":"\n \n \n Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016\n \n \nPlandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016\n \n LONDON, UNITED KINGDOM--(Marketwired - Dec 28, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (\"Plandaí\" or \"the Company\"), a producer of highly bioavailable Phytofare® Catechin Complex, today reviewed the results and current standings for 2015 and discussed plans for the future as they look to 2016.\n Roger Baylis-Duffield, Chief Executive Officer for Plandaí, stated, \"Earlier in 2015, the company commenced production and sale of its Phytofare® Catechin Complex, a green tea-derived extract that which been clinically proven to have ten times greater oral bioavailability over generic catechin extracts and proven topical anti-aging benefits in skin hydration, scaliness, and roughness. Production was compromised, however, when a freak hailstorm destroyed most of our final crop. During the dormant tea-harvesting period, the factory underwent a thorough overhaul and reopened in late September. By December the factory was processing eight tons of leaf per day and, commencing January 2016, production is scheduled to increase to ten tons a day. Assuming we maintain this level of production continues through at least the end of May, Plandaí expects to have over 2 tons per month of Phytofare catechin complex available to sell to customers.\n \"From a sales standpoint,\" Mr. Duffield continued, \"we've been fortunate to garner interest in Phytofare® from multiple large companies in the nutraceutical industry and have been steadily shipping product to customers since May of this year. We have striven to manage our costs and, owing in part to the strong dollar against the South African Rand, we are favorably positioned with respect to operations. Combined with our sales forecasts, we aim to achieve profitability by May 2016.\n \"We are currently completing the processing and extraction protocols including product profiling to begin producing Phytofare® Citrus Bioflavonoid Complex in late June when the tea goes dormant. Third party studies have shown that a high-dose citrus complex is effective in treating cold and flu symptoms, soft tissue injuries and inflammation. Our Phytofare® Cit...